hR-411

N/A

Report date: 2025/03/20 15:48:01

Base Information

Drug NamehR-411
Drug Alias NameIg-Fc/CXCL11 fusion protein (Radikal)
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionC-X-C Motif Chemokine Ligand 11 modulatorsFc receptors modulators
TargetsC-X-C Motif Chemokine Ligand 11Fc receptors
Therapy Area/IndicationsMultiple SclerosisPulmonary FibrosisInflammatory Bowel Diseases +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSalzman
China Registration ClassN/A

Develop Information

Active CompaniesSalzman
Inactive CompaniesN/A
Active IndicationsMultiple SclerosisPulmonary FibrosisInflammatory Bowel Diseases +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A